KORAS / EUPILOS
The DENEX HTN clinical Program
The DENEX System has been evaluated for the treatment of hypertension in the below clinical trials as part of the DENEX HTN Clinical Program.
DENEX HTN-KOrea Regulatory Approval Study is a prospective, multicenter, no-treatment controlled, randomized, open-label, pivotal study to evaluate the Safety and Efficacy of DENEX, Renal Denervation Therapy, in patients with Hypertension on no or 1-3 antihypertensive medications in Korea. Enrollment in DENEX HTN-KORAS began July 2020.
Am I a candidate for the study? If you answered, “YES”, please press the below button to get more information.
Are you between 19 and 75 years of age?
Is your blood pressure greater than 140/90 mmHg?
Would you interested in trying an alternative to medication?
DENEX HTN-EUropean PILOt Study is a prospective, multicenter, sham-controlled, single-blinded, randomized, pilot study to evaluate the safety and efficacy of DENEX system, renal denervation therapy, in patients with hypertension without antihypertensive treatment in Europe. Enrollment in DENEX HTN-EUPILOS will begin September 2022